Nantahala Capital Management, LLC Q1 2024 Filing
Filed May 15, 2024
Portfolio Value
$1.8T
Holdings
118
Report Date
Q1 2024
Filing Type
13F-HR
All Holdings (118 positions)
| Stock | Value |
|---|---|
FBIOFORTRESS BIOTECH INC | $556K |
PERFPERFECT CORP | $496K |
EVOKEUREVOKE PHARMA INC | $412K |
ANTXAN2 THERAPEUTICS INC | $319K |
LADRLADDER CAP CORP | $285K |
EWTXEDGEWISE THERAPEUTICS INC | $244K |
APSGBPAPTOSE BIOSCIENCES INC | $147K |
LUCDLUCID DIAGNOSTICS INC | $132K |
—BM TECHNOLOGIES INC | $125K |
TACTTRANSACT TECHNOLOGIES INC | $125K |
XGNEXAGEN INC | $118K |
RNLXUSDRENALYTIX PLC | $101K |
CUECUE BIOPHARMA INC | $50K |
GFAIGUARDFORCE AI CO LTD | $50K |
—GAMIDA CELL LTD | $29K |
TCBWFTC BIOPHARM HOLDINGS PLC | $5K |
DMPIEURKINTARA THERAPEUTICS INC | $1K |
ARHSARHAUS INC | $15 |
PreviousPage 2 of 2